Literature DB >> 22378469

The optimal timing of antihypertensive medication administration for morning hypertension in patients with cerebral infarction.

Naohisa Hosomi1, Yoshimasa Sueda, Hisashi Masugata, Hiroaki Dobashi, Koji Murao, Masaki Ueno, Takanori Miki, Masakazu Kohno, Akira Nishiyama, Masayasu Matsumoto.   

Abstract

Morning hypertension is an independent risk factor for cardiovascular diseases, particularly stroke. However, the optimal time at which to take antihypertensive medication to treat morning hypertension remains unclear. We prospectively enrolled elderly patients (over 65 years old) with morning hypertension who had suffered an ischemic stroke (or strokes). Additional treatments (one of six arms) were randomly administered for 10 weeks in the morning, in the evening or at bedtime (n=15 for each time point/medication). The patients measured their blood pressure and heart rate at home for 14 days prior to the intervention and for the final 14 days, and recorded the data in a blood pressure diary. The patients' urinary albumin/creatinine ratios were evaluated before and after the 10-week intervention. A total of 270 patients were enrolled in this study (mean age: 75.6±5.8 years; female/male ratio: 125/145). Their morning and evening systolic blood pressures were significantly decreased after following any of the study medication dosing schedules (P<0.001). However, the reductions in the differences between the morning and evening systolic blood pressures were significant only when the medication was taken in the evening or at bedtime (P<0.001 with repeated measures analysis of variance). Furthermore, the recovery rate from morning hypertension was also higher when the medication was taken in the evening (40.0%) or at bedtime (45.6%), rather than in the morning (22.2%; P=0.003 with the χ(2)-test). Antihypertensive medication taken in the evening or at bedtime is the most effective in treating morning hypertension when the patient adheres to the medication regimen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378469     DOI: 10.1038/hr.2012.25

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Serum Resistin Levels May Contribute to an Increased Risk of Acute Cerebral Infarction.

Authors:  Xiao-Liu Dong; Shi-Jun Xu; Li Zhang; Xiu-Qing Zhang; Ting Liu; Qiu-Yan Gao; Qing-Qiang Qian; Bao-Liang Sun; Ming-Feng Yang
Journal:  Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.590

2.  Diagnostic value of combined serological markers in the detection of acute cerebral infarction.

Authors:  Xiaowen Zhao; Min Zhao; Baojun Pang; Yingnan Zhu; Jizhu Liu
Journal:  Medicine (Baltimore)       Date:  2021-09-10       Impact factor: 1.817

Review 3.  Interventions for deliberately altering blood pressure in acute stroke.

Authors:  Philip M W Bath; Kailash Krishnan
Journal:  Cochrane Database Syst Rev       Date:  2014-10-28

4.  Metabolic changes in acute cerebral infarction: Findings from proton magnetic resonance spectroscopic imaging.

Authors:  Ai-Qin Lin; Ji-Xin Shou; Xue-Yuan Li; Lin Ma; Xiao-Han Zhu
Journal:  Exp Ther Med       Date:  2013-11-19       Impact factor: 2.447

5.  Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients.

Authors:  Sarah Leyking; Karin Budich; Kai van Bentum; Stephan Thijssen; Hashim Abdul-Khaliq; Danilo Fliser; Martina Sester; Urban Sester
Journal:  J Transl Med       Date:  2015-02-06       Impact factor: 5.531

6.  Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction.

Authors:  Jiang Ke; Mou Jing
Journal:  Biomed Rep       Date:  2016-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.